About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
Academic rigor, journalistic flair
Articles on Unaffordable medicine
Displaying all articles
Small-batch brewers are starting to tinker with biologic drugs to meet their own medical needs. A side effect of their success would be a disruption to how big pharma makes and distributes drugs.
The high cost of cancer drugs in South Africa has come under the spotlight with an investigation by the Competition Commission in the country.
Top contributors
-
Associate Professor and Course Leader: Post Graduate Programmes in Clinical Pharmacy in the Department of Pharmacy, Sefako Makgatho Health Sciences University
-
Professor, Abell Chair in Synthetic Biology, Colorado State University
-
Postdoctoral Researcher in Chemical and Biological Engineering, Colorado State University
-
Assistant Professor of Medicine, University of Pittsburgh
